Navigation Links
Pervasis Therapeutics Awarded Four Grants Under the Qualifying Therapeutic Discovery Project
Date:11/5/2010

CAMBRIDGE, Mass., Nov. 5, 2010 /PRNewswire/ -- Pervasis Therapeutics, Inc. today announced that it has been awarded over $920,000 in grants through the U.S. government's Qualifying Therapeutic Discovery Project, which provides tax credits and grants to projects that show significant potential to produce new therapies, reduce long-term health care costs, or significantly advance the goal of curing cancer within the next 30 years.  

Pervasis is a clinical stage company focused on developing breakthrough therapies with the potential to improve outcomes following common vascular surgical and interventional procedures, such as arteriovenous access, angioplasties, stents and peripheral and coronary bypass grafts—the failure of which result in serious complications and a significant increase in medical costs. There are no currently approved therapies that directly target the underlying physiological processes leading to serious vascular complications, including inflammation, thrombosis (the formation of a blood clot inside a blood vessel) and restenosis (the re-narrowing of a coronary artery after it has been treated with angioplasty or stenting).

Pervasis' therapies harness the power of the endothelium, the thin layer of cells that lines the interior surface of blood vessels, which has a well-understood role in regulating many of the body's healing processes, including vascular repair. Because these endothelial formulations secrete several key factors involved in combating inflammation and restenosis, they may also be applicable to other therapeutic fields where surgical or interventional procedures are required, including inflammatory disease, orthopedic injury and cancer.

The grants awarded to Pervasis span several therapeutic fields for which the company's therapies have application including:

  • Development of PVS-10200 for Peripheral Artery Disease ($244,479.25)
  • Development of Vascugel® to Sustain Arteriov
    '/>"/>

  • SOURCE Pervasis Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
    2. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
    3. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
    4. Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
    5. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
    6. Cell Therapeutics Awarded $977,917 in Grants Under the Therapeutic Discovery Tax Credit Program
    7. Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial
    8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri®
    9. Shield Therapeutics Signs Agreement With AOP Orphan for ST10-021
    10. Echo Therapeutics to Present at the LifeTech Capital 1st Annual Miami Medical Investors Conference
    11. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/22/2014)... Children,s National Health System has announced ... 5 p.m. EDT for its "Make Your Medical ... continued strong interest from inventors.  Two ... to the winning presentations at the Sheikh Zayed Institute ... Children,s National in October. For competition details,  click ...
    (Date:9/22/2014)... , Sept. 22, 2014  Continua and ... in healthcare technology, media and telecommunications,  have formed ... China and promote international ... BHG announced this new partnership during the global ... Washington, DC , while also ...
    (Date:9/22/2014)... DUBLIN , Sept. 22, 2014 ... addition of the "Global Ablation Technologies (Radiofrequency, ... to 2019" report to their offering. ... technology, the global ablation technologies market has been ... electrical, ultrasound, microwave, cryotherapy, hydrothermal, and hydromechanical ablation ...
    Breaking Medicine Technology:Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3
    ... Pharmasset, Inc. (Nasdaq: VRUS ) announces that ... to be held September 20-22, 2010 at the Grand Hyatt, ... Officer, will provide an overview of the company at the ... (ET). To access a simultaneous webcast of Mr. ...
    ... (NYSE: ALR ) announced today that, in connection ... due 2018, it entered into a purchase agreement with the ... size of the offering was increased from $350.0 million to ... are being offered at 100.0% of the aggregate principal amount ...
    Cached Medicine Technology:Pharmasset to Present at the UBS Global Life Sciences Conference 2Pharmasset to Present at the UBS Global Life Sciences Conference 3Alere Inc. Announces Pricing of Senior Subordinated Notes Offering; Offering Size Increased to $400.0 Million 2
    (Date:9/22/2014)... percent of patients undergoing breast cancer surgery require additional ... cancerous tissue in the initial operation. However, researchers at ... tool they developed that will help surgeons better distinguish ... chances for repeat operations. , The ... 2014 in the Proceedings of the National Academy ...
    (Date:9/22/2014)... South Asians living in Canada have a higher rate ... compared with while people, McMaster researchers have found. ... Canadian Medical Association Journal (CMAJ Open) and may ... the fastest-growing ethnic groups in the country is the ... Canada, comprising about three percent of the population. They ...
    (Date:9/22/2014)... 2014 Quincy Bioscience, one of ... promotes National Self-Improvement Month this September. ... should have access to self-improvement resources, especially for ... demand for products that preserve health is growing ... For over six years, Quincy Bioscience has been ...
    (Date:9/22/2014)... York, New York (PRWEB) September 22, 2014 ... associated with the use of power morcellators ( ... LLP notes a new report detailing the continued ... warnings from federal regulators that specifically discouraged these ... physicians believe that the potential cancer risks associated ...
    (Date:9/22/2014)... CareFlight Air & Mobile Services of Miami ... N3+ Dauphin, the latest version of Airbus Helicopters outstanding ... at Miami Valley Hospital in Dayton, Ohio, ... helicopters. , “We have a lot of confidence in ... Emergency, Trauma, and CareFlight. “We’ve been operating Dauphins for ...
    Breaking Medicine News(10 mins):Health News:The fine line between breast cancer and normal tissues 2Health News:Higher risk of heart disease for South Asians in Canada 2Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 2Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 3
    ... 30 nCircle today announced it is,hosting a ... comply with,HIPAA security requirements and leverage the same ... of unprecedented risk and recent,government enforcements to ensure ... more than ever a top priority for many ...
    ... DIEGO, Oct. 30 One errant cough or unexpected,sneeze ... illness and,resulting absenteeism. As the flu season approaches, HR ... The World Health,Organization estimates that the cost of influenza ... and lost productivity can range from $71 billion,to $167 ...
    ... Inc. (NYSE: MYL ),today announced that in accordance ... declared its quarterly dividend of $16.25 per,share (based on ... of $1,000.00 per share) payable on Nov. 17, 2008, ... 31, 2008., Mylan Inc., which provides products to ...
    ... to Educate During Heartburn Awareness ... ... more than 60 million Americans each month(1) and this November, the,National Heartburn ... about treatment options and lifestyle,changes during Heartburn Awareness Month in November., ...
    ... MINNEAPOLIS, Oct. 30 ATS Medical, Inc.,(Nasdaq: ... products and services, today announced it has received ... ATS 3f(R) Aortic,Bioprosthesis., (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ), ... the $400-plus Million U.S.,tissue valve market. Based on ...
    ... announces the following Webcast:, What: Air ... @ 4:15 p.m. ET, Where: http://www.videonewswire.com/event.asp?id=52901 , ... Simply log on to the web at the ... Christine Clarke of Air Methods Corporation, +1-303-792-7579., If you are unable ...
    Cached Medicine News:Health News:nCircle Announces Free Web Seminar - 'Automating HIPAA Compliance with Security & Configuration Auditing' 2Health News:Going 'Green' May Mean Fewer Colds This Season 2Health News:Going 'Green' May Mean Fewer Colds This Season 3Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 2Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 3Health News:ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis 2Health News:ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis 3Health News:ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis 4
    ... of German Craftsmanship have produced ... the world. Ocutek® now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
    ... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
    ... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
    ... platform with integrated neck. Piston assembly ... an internal spring to recoil back ... Block fits into precision milled cavity ... sized 6.25 - 9.0mm. Designed for ...
    Medicine Products: